Please login to the form below

Not currently logged in
Email:
Password:

Boehringer Ingelheim to build $65m US research facility

Will add new R&D operations to its US headquarters in Connecticut

Boehringer Ingelheim is expanding its R&D operations in the US with a new research and development facility.

The $65m facility will be located at the company's US headquarters in Ridgefield, Connecticut and when completed will handle production of active pharmaceutical ingredients used in early development activities.

It brings the total of Boehringer's investment in the US this year to $350m, adding to spending on projects such as a $42m new drug safety assessment building in Ridgefield and a $50m high containment operations facility in Columbus, Ohio.

J Martin Carroll, president and CEO of the company's US operations, said: “These are exciting projects; ones that increase Boehringer Ingelheim's research and development capabilities and reinforce our commitment to growth and innovation in the US.”

“Through these investments we are improving our ability to research, develop and manufacture the medicines of tomorrow and in doing so fulfilling our promise to bring more health to patients and their families.”

15th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics